CN1768838A - Chinese medicine preparation for promoting lead-removal and its preparation process - Google Patents
Chinese medicine preparation for promoting lead-removal and its preparation process Download PDFInfo
- Publication number
- CN1768838A CN1768838A CN 200510100346 CN200510100346A CN1768838A CN 1768838 A CN1768838 A CN 1768838A CN 200510100346 CN200510100346 CN 200510100346 CN 200510100346 A CN200510100346 A CN 200510100346A CN 1768838 A CN1768838 A CN 1768838A
- Authority
- CN
- China
- Prior art keywords
- fructus
- chinese medicine
- lead
- preparation
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a traditional Chinese medicinal preparation for the promotion of lead-discharging and its preparing process, which is prepared from raw materials including bamboo leaves, fresh reed rhizome, rhizoma dioscoreae, Chinese olive, Chinese date, mulberry and conventional medicinal adjuvant.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation that promotes Plumbum removing and preparation method thereof, belong to the field of Chinese medicines.
Technical background
Lead is a kind of human body non-essential element, and it is prevalent in natural atmosphere, soil, water and the food, can not decompose, and easily is absorbed by the body by digestive tract, respiratory tract.Its is put aside in each tissue of human body, and is wherein maximum with the skeleton amount of savings, accounts for and puts aside 85%～90% of lead in the body.
Plumbous affinity to tissue is very strong, can cause multiple organ injury diseases such as liver, brain, with nervous system injury more so, often causes diseases such as peripheral neuritis, motion and paraesthesia.If lead enters cerebral tissue with blood flow, can damage cerebellum and brain cortex cell, disturb metabolic activity, cause nutrient substance and oxygen supply deficiency, thereby symptoms such as headache, hypomnesis, insomnia appear, also often with gastrointestinal symptoms such as inappetence, gastroenteritis, stomachache.
Plumbous particularly serious to the harm of children's health and intellectual development, the energy force rate adult that the child resists the lead poisoning evil is poor; Child's living habit etc. causes the lead ratio adult who takes in by digestive tract and respiratory tract many; The lead that the adult takes in has 94% savings in sclerotin, the child then has only 70%, all the other 30% are stayed in the blood, child's blood brain barrier is grown imperfection, and permeability is big, and blood lead is easy to see through blood brain barrier brain is produced murder by poisoning, as untimely removing, along with the growth of blood brain barrier is perfect, the lead that storage is stayed in the brain is difficult to get rid of, and may cause child's brain permanent lesion and mental retardation.1991 American National Center for Disease Control (CDC) (CDC) on the basis of a large amount of clinical and epidemiologic datas, the diagnostic criteria of determining children ' s lead poisoning is BPb 〉=100ug/L, and no matter whether corresponding symptom and other blood and chemical change are arranged, this standard is accepted by the various countries scholar, certainly children ' s lead poisoning described here is not represented the poisoning on the clinical meaning, but lead load has been in the danger level that impairs children's health in the expression body.
Preventing and treating saturnine basic principle is environment intervention, health education and clinical treatment three combinations, the environment intervention is basic, health education is a basic means, and to being that the lead poisoning of BPb 〉=200ug/L is just considered clinical treatment more than the moderate, this is because the clinical treatment medicine mainly contains calcium disodium chelate (CaNa at present
2EDTA), sodium dimercaptosuccinate (DMSA) etc., though driving lead, medicine can reduce lead load in the body, Plumbum removing is effective, but the side effect that has renal damage and essential trace element to run off, and drive nervous lesion that plumbous medicine causes lead and reverse and have little significance, so the medicine Plumbum removing removes the severe lead poisoning, clinically generally do not adopt.
Chinese invention patent publication number CN1465285A discloses " lead-removing health care food food and preparation method thereof ", adopting chitosan, oligochitosan, Radix Glycyrrhizae, Poria extract is main effective ingredient, though it embodies lead-eliminating effect, but each primary raw material in its patent disclosure, especially chitosan, oligochitosan prepare complicated, wherein oligochitosan is by the preparation of Chinese patent 00110009.2 method, relates to membrane production equipment cost height, and industrialization may be subjected to certain constraint; Chinese invention patent publication number CN1506070A discloses " a kind of Pb excluding health care product that contains stachyose ", adopts stachyose, zinc lactate, ferrous lactate, V
CAnd V
B1Be primary raw material." falling plumbous liquid and preparation method thereof " of Chinese invention patent Granted publication CN1052864C bulletin, adopting Thallus Laminariae (Thallus Eckloniae) immersion, edible aminoacids complex, A.chinensis Planch. extracting solution, Semen Helianthi extracting solution is primary raw material.These inventions are to a certain degree promoting plumbous discharge the in the body, but curative effect can not be satisfactory.
Summary of the invention
Primary and foremost purpose of the present invention provides a kind of Chinese medicine preparation of promotion Plumbum removing of medicine and food raw materials composition.Under Chinese medical theory instructed, by the rational proportion of each medical material, synergism promoted plumbous eliminating the in the body, and lead poisoning and toxic damages are had excellent prevention and therapeutic effect.
Another one purpose of the present invention provides the preparation method of this Chinese medicine preparation.
The raw material consumption (weight portion) of preparation medicine activity component of the present invention is: Herba Lophatheri 20-50 part, fresh Rhizoma Phragmitis 30-60 part, Rhizoma Dioscoreae 15-30 part, Fructus Canarii 15-30 part, Fructus Jujubae 10-30 part and Fructus Mori 10-30 part.Each raw material optimum ratio is: 15 parts in 30 parts of Herba Lophatheris, 50 parts of fresh Rhizoma Phragmitis, 20 parts of Rhizoma Dioscoreaes, 20 parts of Fructus Canariis, 15 parts in Fructus Jujubae and Fructus Mori.
Medicine of the present invention can adopt the Chinese medicine preparation conventional method to be prepared into conventional oral formulations:
With Herba Lophatheri, fresh Rhizoma Phragmitis, Rhizoma Dioscoreae, Fructus Canarii, Fructus Jujubae, Fructus Mori mixes according to above-mentioned weight ratio, adds 9-10 times of water gaging and soaks 2-3 hour, and heating decocts, the after-filtration that boils, medicinal residues add 9-10 times of water gaging again and are heated to and boil, and after-filtration boils, filtrate merges, put high speed centrifuge and separate solid content, supernatant concentration to relative density is 1.05-1.06, preferred 1.06 o'clock, advance spray dryer, 140-160 ℃ of inlet temperature control, preferred 150 ℃, leaving air temp 100-110 ℃, preferred 105 ℃, 50-70 rev/min of nebulizer rotating speed, preferred 60 rev/mins, charging rate is 3-6ml/ minute, preferred 5ml/ minute, get spray drying powder, pulverize, can get fine powder after sieving.The various conventional adjuvant of needs when this fine powder can add the preparation different dosage form, the method for Chinese medicinal of routines such as lubricant, binding agent is prepared into the common Chinese medicine preparation formulation, as tablet, capsule, oral liquid, electuary etc.
The traditional Chinese medical science thinks that lead is the heresy of YIN-cold, and property is moistened sliding heavy the bob, interior logical Liver and kidney, so that the gasification function of kidney is not enough and cause a series of poisoning manifestations.The liver and the kidney have a common source, and deficiency of kidney-YIN is deficiecny of liver-YIN then.So in treatment, should be adjusted to then so that toxin expelling dampness removing, warming and recuperating the kidney-YANG, QI and blood are two.
Plumbum removing Chinese medicine preparation of the present invention selects Herba Lophatheri, fresh Rhizoma Phragmitis, Rhizoma Dioscoreae, Fructus Canarii, Fructus Jujubae and Fructus Mori to carry out the combined preparation active component; Wherein Herba Lophatheri property slightly sweet flavor is cold, GUIXIN stomach-intestinal warp, clearing away heat and promoting diuresis.Fresh Rhizoma Phragmitis is sweet cold, returns lung stomach warp, the clearing away heat and promoting production of body fluid diuresis.The sweet acid of Fructus Canarii is flat, returns lung stomach warp, the clearing away heat and promoting production of body fluid detoxifcation.Rhizoma Dioscoreae is sweet flat, returns spleen lung kidney channel, the spleen reinforcing dampness removing that promotes the production of body fluid.The shared toxin expelling dampness removing effect that plays of above-mentioned four Chinese medicine.The sweet acid of Fructus Mori is cold, GUIXIN Liver and kidney warp, the YIN nourishing of enriching blood.The sweet temperature of Fructus Jujubae is returned the taste warp, the invigorating the spleen and replenishing QI nourishing blood to tranquillize the mind.Above-mentioned all medicines share, and reach toxin expelling dampness removing, warming and recuperating the kidney-YANG, the two accent effects of QI and blood, play at above-mentioned lead poisoning to promote plumbous eliminating effect in the body.
The present invention is that screening obtains having each Chinese medicine that clearly promotes lead-eliminating effect from medicine and food raw materials, can reach and promote the plumbous purpose of human body being damaged, improves symptom of Plumbum removing, alleviation or prevention, and have no side effect, be suitable for the higher crowd of blood lead and take for a long time, especially at the child.
The specific embodiment
The invention will be further elaborated below in conjunction with embodiment
Embodiment 1: preparation tablets of the present invention
1. take by weighing each crude drug by following weight proportion
Herba Lophatheri 300 grams, fresh Rhizoma Phragmitis 500 grams, Rhizoma Dioscoreae 200 grams, Fructus Canarii 200 grams, Fructus Jujubae 150 grams, Fructus Mori 150 grams, standby;
2. the Herba Lophatheri of above-mentioned weight proportion, fresh Rhizoma Phragmitis, Rhizoma Dioscoreae, Fructus Canarii, Fructus Jujubae, Fructus Mori add 10 times of water gagings immersions 3 hours, and heating decocts, and after-filtration boils, medicinal residues add 10 times of water gagings again and are heated to and boil, the after-filtration that boils, and filtrate merges, put high speed centrifuge and separate solid content, get supernatant;
3. supernatant concentration to relative density is 1.06 o'clock, advances spray dryer, 150 ℃ of inlet temperature controls, and 105 ℃ of leaving air temps, 60 rev/mins of nebulizer rotating speeds, charging rate is 5ml/ minute, gets spray drying powder 135 grams;
4. pulverize spray drying powder and become fine powder, add adjuvant and make granule, drying, tabletting.
Embodiment 2: capsule preparation of the present invention
1, takes by weighing each crude drug by following weight proportion
Herba Lophatheri 300 grams, fresh Rhizoma Phragmitis 500 grams, Rhizoma Dioscoreae 200 grams, Fructus Canarii 200 grams, Fructus Jujubae 150 grams, Fructus Mori 150 grams, standby;
2, the Herba Lophatheri of above-mentioned weight proportion, fresh Rhizoma Phragmitis, Rhizoma Dioscoreae, Fructus Canarii, Fructus Jujubae, Fructus Mori add 10 times of water gagings immersions 3 hours, and heating decocts, and after-filtration boils, medicinal residues add 10 times of water gagings again and are heated to and boil, the after-filtration that boils, and filtrate merges, put high speed centrifuge and separate solid content, get supernatant;
Supernatant concentration to relative density is 1.06 o'clock, advances spray dryer, 150 ℃ of inlet temperature controls, and 105 ℃ of leaving air temps, 60 rev/mins of nebulizer rotating speeds, charging rate is 5ml/ minute, gets spray drying powder 135 grams; Pulverize spray drying powder and become fine powder, add adjuvant, mixing, the snap fit capsule of packing into.
Embodiment 3: to the Ergonomy evaluation experimental of Chinese medicine of the present invention
50 of healthy Kunming mouses, a cleaning level animal, male female half and half, body weight 18～22 grams; Animal is divided into 5 groups, and promptly the blank group is dyed plumbous model group, 3 dosage groups of high, medium and low Semen Cassiae decocting liquid, and 10 every group, lead acetate is dissolved in the distilled water by the 40mg/kg lumbar injection, set up mice and dye plumbous animal model.
The Chinese medicine of the embodiment of the invention 1 adopts conventional decocting method preparation, and simmer down to respective concentration, medication group gastric infusion, decocting liquid various dose group comprises high dose group (20g/kg), middle dosage group (10g/kg), low dose group (5g/kg) is gastric infusion respectively, and all the other each groups gavage the equivalent normal saline, and the experiment successive administration is totally 6 weeks.Administration is got mice right femoral vein blood 60ul after finishing, and puts into the plastic centrifuge tube with cover that fills 0.5ml1% nitric acid and shakes up; Get a side 50% femur, digest after weighing, add rare nitric acid and be settled to 5ml, with corresponding liver and the cerebral tissue got of method, with atomic spectrophotometer carry out blood and bone, liver, the brain lead content is measured; Above-mentioned data statistics is checked with T.See Table 1.
The Chinese medicine of table 1 embodiment of the invention 1 to mice blood lead, bone lead, liver and brain lead (mg/kg) content influence (x ± s, n=10)
| Group | Dosage (g/kg) | Blood lead (mg/kg) | Bone lead (mg/kg) | Liver lead (mg/kg) | Brain lead (mg/kg) |
| Dosage group high dose group in the blank model contrast low dose group | 0.0 0.0 5 10 20 | 0.05±0.01 1.75±0.01 b 0.52±0.25 0.32±0.21 a 0.12±0.07 a | 1.32±0.87 176.2±28.5 b 156.5±29.1 a 131.8±27.5 a 123.5±18.5 a | 0.51±0.03 2.62±0.73 1.19±0.31 a 1.07±0.62 a 0.82±0.25 b | 16.2±14.8 39.6±17.6 33.7±15.3 29.5±16.2 28.3±13.4 a |
aCompare with model group P＜0.05
bCompare with blank group P＜0.01
Being tried thing influences obviously blood lead content, and middle high dose group and model group relatively have significant difference P＜0.05; Being tried thing influences obviously the bone lead content, and low middle high dose group and model group relatively have significant difference P＜0.05; Being tried thing influences obviously the liver lead content, and low middle high dose group and model group relatively have significant difference P＜0.05-0.01; Being tried thing influences obviously the brain lead content, and high dose group and model group relatively have significant difference P＜0.05;
Embodiment 4: anthroposcopy test of the present invention
1 clinical data selects 69 examples that 6～12 years old child of plumbous contact history arranged, and Pb-B all more than 100 μ g/L, has been got rid of the child of systemic diseases such as suffering from cardiovascular, liver, kidney and hemopoietic system and chronic diarrhea arranged and dyspeptic child; Do not take and tried thing or add other article identical, influence effect and judge or the infull child of data with the observation effect.Counter point between own control and group is adopted in this test, with satisfactory 64 routine children, be divided into Semen Cassiae decocting liquid group and placebo group randomly according to blood lead, lead in urine level, observation group's 36 examples, man's 17 examples, women 19 examples, age average (9.87 ± 2.68) year, lead content in urine average out to (5.23 ± 2.35) (μ g/L), blood lead content average out to (135.51 ± 19.16) (μ g/L); Matched group 33 examples, male 16 examples, women 17 examples, 6～12 years old age, average (9.56 ± 2.28) year, lead content in urine average out to (6.91 ± 4.62) (μ g/L), blood lead content average out to (136.43 ± 22.18) (μ g/L).Two groups of basic conditions compare, and difference does not have significance (P＞0.05), has comparability, carries out clinical observation by blind method.
2 laboratory observation medicines and instructions of taking laboratory observation medicine are the medicine of embodiment 2 preparation, and child every day early, respectively take each 1 gram evening 1 time; Respectively take matched group child every day the comfort oral liquid sooner or later and tried that beyond the region of objective existence is seen, taste is basic identical; All accepted to observe 30 days for two groups.
Before 3 observation index are observed and observe back blood lead and lead in urine output.
4 statistical procedures data represent with mean ± standard deviation, self paired data pairing T check, T check between data set in groups.
5 results
Before and after observing self relatively, blood lead content obviously descends, the lead in urine output, obviously increase.See Table 2
Treatment of table 2 liang group and treatment back blood lead and lead content in urine be (μ g/L, x ± s) relatively
| Group | Lead in urine | Blood lead | |||
| The example number | Before the treatment | Treated 30 days | Before the treatment | Treated 30 days | |
| Observe | 36 | 5.23±2.35 | 9.59±3.02 △ | 135.51±19.16 | 82.18±17.26 ▲▲ |
| Contrast | 33 | 6.91±4.62 | 6.37±3.11 △△ | 136.43±22.18 | 135.25±22.16 ▲ |
Annotate:
△Self compare with observation is preceding P＜0.05,
△ △P＜0.01, and compare between observation group's group,
▲Compare with observation group P＜0.01,
▲ ▲Compare before and after P＜0.01 observation group self.
By table 2 as seen, observe children taking after 30 days blood lead content obviously descend, observation group self relatively and observe between back observation group and matched group group and compare, blood lead and lead content in urine difference have significance (P＜0.01).
Claims (6)
1, a kind of Chinese medicine preparation that promotes Plumbum removing, the active component that it is characterized in that it mainly is to be made by the raw material of following weight portion: Herba Lophatheri 20-50 part, fresh Rhizoma Phragmitis 30-60 part, Rhizoma Dioscoreae 15-30 part, Fructus Canarii 15-30 part, Fructus Jujubae 10-30 part and Fructus Mori 10-30 part.
2, Chinese medicine preparation according to claim 1, wherein the consumption of each crude drug is: 15 parts in 30 parts of Herba Lophatheris, 50 parts of fresh Rhizoma Phragmitis, 20 parts of Rhizoma Dioscoreaes, 20 parts of Fructus Canariis, 15 parts in Fructus Jujubae and Fructus Mori.
3, Chinese medicine preparation according to claim 1 is characterized in that: make oral formulations by described each crude drug.
4, the preparation method of Chinese medicine preparation according to claim 3 comprises the steps:
1) it is standby to take by weighing each crude drug Herba Lophatheri, fresh Rhizoma Phragmitis, Rhizoma Dioscoreae, Fructus Canarii, Fructus Jujubae and Fructus Mori;
2) Herba Lophatheri, fresh Rhizoma Phragmitis, Rhizoma Dioscoreae, Fructus Canarii, Fructus Jujubae, the Fructus Mori by above-mentioned weight proportion adds 9-10 times of water gaging immersion 2-3 hour, and heating decocts, and after-filtration boils, medicinal residues add 9-10 times of water gaging again and are heated to and boil, the after-filtration that boils, and filtrate merges, put high speed centrifuge and separate solid content, get supernatant;
3) supernatant concentration is advanced spray dryer when relative density is 1.05-1.06,140-160 ℃ of inlet temperature control, leaving air temp 100-110 ℃, 50-70 rev/min of nebulizer rotating speed, charging rate is 3-6ml/ minute, spray drying powder;
4) spray drying powder is pulverized, and sieves, and gets fine powder, is the active component of Chinese medicine preparation of the present invention.
5, preparation method according to claim 4, active component and additive of tablet mixed pressuring plate that step 4) is got.
6, preparation method according to claim 4 is mixed the active component that step 4) gets with the capsule adjuvant, encapsulated.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510100346XA CN100350954C (en) | 2005-10-19 | 2005-10-19 | Chinese medicine preparation for promoting lead-removal and its preparation process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510100346XA CN100350954C (en) | 2005-10-19 | 2005-10-19 | Chinese medicine preparation for promoting lead-removal and its preparation process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1768838A true CN1768838A (en) | 2006-05-10 |
| CN100350954C CN100350954C (en) | 2007-11-28 |
Family
ID=36750543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200510100346XA Expired - Fee Related CN100350954C (en) | 2005-10-19 | 2005-10-19 | Chinese medicine preparation for promoting lead-removal and its preparation process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100350954C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100418558C (en) * | 2006-05-31 | 2008-09-17 | 暨南大学 | Application of areca and extract thereof in preparation of health product for expelling lead |
| CN102972752A (en) * | 2012-08-21 | 2013-03-20 | 苏州谷力生物科技有限公司 | Composition having heavy metal removing function |
| CN104127731A (en) * | 2014-08-01 | 2014-11-05 | 李玲 | Traditional Chinese medicine composition for treating liver and kidney deficiency type child lead poisoning |
| CN105727147A (en) * | 2016-04-13 | 2016-07-06 | 张雪燕 | Medicine composition for preventing and treating chronic renal injury caused by lead poisoning and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1141780A (en) * | 1995-07-28 | 1997-02-05 | 周正义 | Human-body purifying agent |
| CN1535598A (en) * | 2003-04-07 | 2004-10-13 | 吴凤锷 | Instant vermicelli and its production method |
-
2005
- 2005-10-19 CN CNB200510100346XA patent/CN100350954C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100418558C (en) * | 2006-05-31 | 2008-09-17 | 暨南大学 | Application of areca and extract thereof in preparation of health product for expelling lead |
| CN102972752A (en) * | 2012-08-21 | 2013-03-20 | 苏州谷力生物科技有限公司 | Composition having heavy metal removing function |
| CN104127731A (en) * | 2014-08-01 | 2014-11-05 | 李玲 | Traditional Chinese medicine composition for treating liver and kidney deficiency type child lead poisoning |
| CN105727147A (en) * | 2016-04-13 | 2016-07-06 | 张雪燕 | Medicine composition for preventing and treating chronic renal injury caused by lead poisoning and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100350954C (en) | 2007-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102526474B (en) | Chinese medicine composition for treating neurasthenia | |
| CN108434242A (en) | A kind of pharmaceutical composition, preparation method and its usage for treating diabetes and its complication | |
| CN1895547B (en) | Medicine for treating diabetes and its preparation | |
| CN100350954C (en) | Chinese medicine preparation for promoting lead-removal and its preparation process | |
| CN109528904A (en) | A kind of kidney-tonifying health-care, boosting qi and nourishing yin, pharmaceutical composition of high-content ginsenoside and preparation method thereof | |
| CN102258628B (en) | Chinese medicinal composition with lead removal promoting effect | |
| CN110772564A (en) | Traditional Chinese medicine extract composition with depression mood regulating effect, preparation method thereof and traditional Chinese medicine preparation | |
| CN1814214A (en) | Chinese medicine composition for treating body thin and delicate coustitution, and preparing method | |
| CN101647985B (en) | Medicament composition for treating psoriasis | |
| CN104524292A (en) | Application of traditional Chinese medicine preparation in preparation of medicament for treating obesity | |
| CN106173128A (en) | A kind of chocolate with anti-fatigue effect and preparation method thereof | |
| CN100394930C (en) | Application of cassia seed in preparation of lead-remove promoting drug or health-caring product | |
| CN103933282B (en) | A kind of Chinese medicinal capsule for treating diabetes | |
| CN105288501A (en) | Traditional Chinese medicine composition containing folium artemisiae argyi and treating obesity | |
| CN101884760B (en) | Chinese medicinal composition for treating diabetes mellitus and preparation method thereof | |
| CN105287943A (en) | Compound fructus cannabis capsules, preparation method and applications thereof | |
| CN109999167A (en) | A kind of Chinese medicine composition having both conditioning mood and health of losing weight | |
| CN104547738A (en) | Traditional Chinese medicine preparation for treating obesity and preparation method of traditional Chinese medicine preparation | |
| CN1883593A (en) | Blood-nourishing oral liquid with nine ingredients | |
| CN112076305A (en) | A Chinese medicinal oral and topical stock solution mixture for treating metabolic syndrome and resisting bacteria and inflammation | |
| CN109674982A (en) | Composition, preparation method and application with invigorating the spleen dehumidification function | |
| CN1233416C (en) | Compound pepsin powder for treating child dyspepsia and its preparation method | |
| CN101229331B (en) | Medicine for treating anorexia, limosis and preparing method thereof | |
| CN108815342B (en) | Traditional Chinese medicine composition for treating male infertility | |
| CN107669782A (en) | A kind of Chinese medicinal granule product for reducing blood glucose and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071128 Termination date: 20101019 |